Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can tailored meals ease lung cancer treatment side effects?

NCT ID NCT04986670

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether providing medically tailored meals along with nutrition counseling can improve the health and well-being of lung cancer patients who are economically disadvantaged or from minority groups. About 299 patients from four U.S. medical centers will receive remote nutrition counseling and meals for 6 to 8 months. Researchers will track changes in diet, weight, food security, and common treatment side effects like fatigue and nausea.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
medically tailored meals plus nutrition counseling
What this could lead to
If successful, this could show that combining tailored meals with counseling helps lung cancer patients eat better, feel less sick from treatment, and have a better quality of life.
What could go wrong
This is a behavioral intervention study, not a drug trial, so benefits may be modest. Results depend on patient adherence, and the study is still ongoing with no final outcomes yet.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

299 people

The number who actually took part.

Started

Nov 2020

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adults (18+ years of age) 2. Newly diagnosed patients with lung cancer (non-small cell and small cell lung cancer): * Patients with stages I-III lung cancer: 1\) starting multimodality therapy including chemoradiation (either concurrent or sequential), systemic treatment, or radiation alone; and may be followed by surgery; or 2) starting adjuvant therapy after lung resection ((chemotherapy alone, radiation alone, or chemoradiation (either concurrent or sequential)) * Patients with stage IV lung cancer or recurrent/metastatic: Eligible at diagnosis and for up to 3 months after starting treatment o Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0-3 3. Vulnerable patients who meet at least one of the following criteria: * Economically disadvantaged (household gross monthly income at or below 130% of the Federal Poverty Level) * Racial and ethnic minorities (African Americans, American Indians and Alaska Natives, Asians and Pacific Islanders, and Hispanics) * No health insurance * Elderly patients (ages 65 years or older) * Reside in rural areas (non-metropolitan counties with less than 50,000 people) 4. Voluntarily provide consent, HIPPA authorization form, and consent from treating oncologist. 5. Able to speak and read English themselves or with minimal help. 6. Able to receive medically-tailored meals for the course of the study if being assigned to the intervention arm, and willing to sign the MTM agreement. Exclusion Criteria: 1. Cognitively unable to consent or have physical or mental limitations that would prevent full participation in the program. 2. Have medical conditions that significantly impact digestion, metabolism, or food intake (e.g., surgical loss of esophagus, stomach, or colon; pancreas dysfunction; brain surgery that alters cognition; severe food allergies; etc.) or have active metabolic or digestive illnesses (i.e., Celiac disease, IBS, renal insufficiency, hepatic insufficiency). 3. Pregnant or planning to become pregnant during the study. 4. Unable to receive medically-tailored meals for the course of the study if being assigned to the intervention arm, including lack of a permanent address to which meals can be delivered (a friend or home address is acceptable given it is used on a consistent basis), not having a fully functioning kitchen with a microwave or oven for cooking, not having a standard-sized refrigerator with a freezer with storage capacity to hold one week's worth of meals; or unwilling to sign the MTM agreement.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung cancer (non-small cell) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania, 19111, United States

  • MD Anderson Cancer Center

    Houston, Texas, 77030, United States

  • The James Cancer Hospital

    Columbus, Ohio, 43210, United States

  • Tufts Medical Center

    Boston, Massachusetts, 02111, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.